A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.
Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.
A Stanford neurosurgeon developed a glove that delivers vibratory bursts of electricity to the fingertips to quell Parkinson's symptoms.
Four years after his death, possibly the greatest mystery famed neuroscientist Ben Barres ever sought to solve has become a bit less opaque.
A new discovery could provide a way of detecting Parkinson's disease in its earliest stages, before symptoms start. And it could accelerate the development of …
Graduate student Johanna O'Day has started an effort that helps Parkinson's patients tell their story and connects researchers and patients.
Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue.
Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.
New research suggests that targeting mitochondria could be a way to treat Parkinson's disease.
